Federal Appellate Court Rejects Preemption Of State Law Claims In Fosamax Litigation
The United States Court of Appeals for the Third Circuit stated in its precedential Opinion filed on September 20, 2024, “Drug manufacturers have the primary responsibility to ensure that the labels on their products comply with federal and state law. In this case, hundreds of Plaintiffs accus[...]